Gracell Biotechnologies Inc. (GRCL) Tops Q1 EPS by 1c

Gracell Biotechnologies Inc. (NASDAQ: GRCL) reported Q1 EPS of ($0.07), $0.01 better than the analyst estimate of ($0.08).

For earnings history and earnings-related data on Gracell Biotechnologies Inc. (GRCL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c